AMIFOSTINE INJECTION 500 MG
| Generic Name | Amifostine |
| Strength | 500 mg |
| Dosage Form | Injection (lyophilized powder) |
| Route of Administration | Intravenous (IV) |
| Therapeutic Class | Cytoprotective Agent |
| Indications | Chemotherapy-induced toxicity, radiotherapy protection |
| Prescription Required | Yes |
| Storage | Store below 25°C and protect from light |
| Manufacturer | As per the pack details |
AMIFOSTINE INJECTION 500 MG
Amifostine Injection 500 mg is a prescription cytoprotective therapy used to safeguard healthy tissues during chemotherapy and radiation treatment. It is especially effective in reducing kidney toxicity caused by cisplatin and protecting salivary glands in patients receiving radiation for head and neck cancers.
Amifostine works by scavenging free radicals and selectively protecting normal cells, ensuring that the anticancer effectiveness of chemotherapy and radiotherapy is maintained. This targeted protection makes it an essential supportive therapy in oncology care.
Administered under medical supervision, Amifostine 500 mg Injection provides clinically proven tissue protection, helping patients tolerate aggressive cancer treatments more safely. Its role in minimizing side effects supports better treatment outcomes and improved quality of life for cancer patients
Product Features
- Cytoprotective agent for chemotherapy and radiotherapy
- Reduces cisplatin-induced nephrotoxicity
- Protects salivary glands during radiation therapy
- Administered intravenously under medical supervision
- Helps minimize treatment-related side effects
- Prescription-only supportive oncology medication
How It Helps
- Scavenges free radicals to protect healthy cells from chemotherapy and radiation damage
- Reduces the risk of kidney toxicity caused by cisplatin treatment
- Protects salivary glands during head and neck radiation therapy
- Supports safer cancer treatment by minimizing treatment-related side effects

Reviews
There are no reviews yet.